ESC2024 Premium Access

Right ventricular to pulmonary artery coupling credicts poor outcomes after interatrial shunting in heart failure

Congress Presentation

About the speaker

Associate Professor Nijad Bakhshaliyev

Bezmialem University, Istanbul (Türkiye)
0 follower

9 more presentations in this session

Dual pathway inhibition in patients with atherosclerosis with and without heart failure: insights from the XATOA Registry

Speaker: Doctor P. Gouda (Edmonton, CA)

Thumbnail

A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.

Speaker: Miss B. Goovaerts (Antwerp, BE)

Thumbnail

A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure

Speaker: Professor J. Udelson (Boston, US)

Thumbnail

Unmasking patients insight into SGLT2 inhibitors- a collaborative quality improvement project to enhance patient education and safety

Speaker: Doctor L. Saad (Coventry, GB)

Thumbnail

Long-acting CRF2 receptor agonist COR-1389 improves cardiopulmonary function parameters in monocrotaline-induced pulmonary hypertension and right heart failure rat model

Speaker: Doctor M. Kowala (Zionsville, US)

Thumbnail

Access the full session

Heart failure: bench to bedside

Speakers: Associate Professor N. Bakhshaliyev, Doctor P. Gouda, Miss B. Goovaerts, Professor J. Udelson, Doctor L. Saad...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations